// Image Slider // Add the new slick-theme.css if you want the default styling

Clinical Management of Dilemmas in Contraception (18-04-06)

21st Annual Premier Women's Healthcare Conference (18-04)

0.75 CE (NCC Code 2A)

Faculty:

Michael Policar, MD, MPH

Professor Emeritus

University of California San Francisco School of Medicine

San Francisco, California

Intended Audience:
Nurse practitioners (NPs), Certified Nurse-Midwives (CNMs), and other advanced practice clinicians who care for women.

                

  • CE Approval Period: Now through December 2019
  • Estimated Time to Complete This Activity: 0.75 hours
  • CE Approval Hours:  0.75 Contact Hours of CE Credit

                               

Educational Objectives:
At the conclusion of this activity, clinicians should be better able to:

  • Describe the 2016 modifications in the CDC MEC regarding the use of hormonal contraceptives in women who are breast-feeding their newborn.
  • Review changes in the labeling of ulipristal emergency contraceptive pills regarding when to initiate hormonal contraceptives.
  • List the steps that should be followed in locating and IUD in a women with "missing strings".
  • Describe management of abnormal vaginal bleeding in women who use oral contraceptives, implants, IUDs, and contraceptive injections.

Successful Completion of the Activity:

Successful completion of this online activity, 18-04-06, requires the participant to:

During the approval period (now through December 2019);

  1. Read the educational objectives, disclosures, and disclaimers on the front page;
  2. Study the material in the learning activity by watching the session;
  3. Complete the post test with a score of 70% or higher;
  4. Complete the session evaluation;
  5. After successful completion you may print your CE certificate.  Your certificate will be stored for you on the NPWH E-Learning site under My Transcripts

           

Program description:

In 2016, the Centers for Disease Control extensively revised the evidence-based contraceptive recommendations in the CDC Medical Eligibility Criteria (MEC) and Selected Practice Recommendations (SPR). Using a case-study format, this presentation will highlight the updated recommendations most applicable to clinical practice. Additional cases will focus on common dilemmas that arise with the use of IUD and contracptive implants, as well as management of abnormal bleeding in women using a variety of hormonal and non-hormonal contraceptives.

                  
Accreditation Statement:

This activity has been evaluated and approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women’s Health (NPWH), and has been approved for 0.75 contact hour(s) of CE credit.  Each participant should claim only those contact hours that he/she actually spent in the educational activity.

              

Activity Number: 18-04-06

      

Faculty Disclosures:
NPWH policy requires all faculty to disclose any affiliation or relationship with a commercial interest that may cause a potential, real, or apparent conflict of interest with the content of a CE program. NPWH does not imply that the affiliation or relationship will affect the content of the CE program. Disclosure provides participants with information that may be important to their evaluation of an activity. All conflicts of interest were resolved according to NPWH policy. In addition, all content has been peer reviewed by a WHNP with no conflicts of interest to ensure the content is evidence-based, un-biased, and uses the best available, highest strength evidence for recommendations. Faculty are also asked to identify any unlabeled/unapproved uses of drugs or devices made in their presentation.

                    

Michael Policar, MD, MPH has disclosed that he has been a litigation consultant (expert witness) for Mirena IUD.

                      

Disclosure of unlabeled use:
NPWH policy requires authors to disclose to participants when presenting information about unlabeled use of a commercial product or device or an investigational use of a drug or device not yet approved for any use.

                        
Therapeutics Disclaimer:

Participating faculty members determine the editorial content of CE activities; this content does not necessarily represent the views of NPWH. This content has undergone a blinded peer review process for validation of clinical content. Although every effort has been made to ensure that the information is accurate, clinicians are responsible for evaluating this information in relation to generally accepted standards in their own communities and integrating the information in this activity with that of established recommendations of other authorities, national guidelines, FDA approved package inserts, and individual patient characteristics.

                       

Commercial Support:
This activity was supported by an educational grant from Merck & Co.

                    

You must be signed in to access this course. You can sign in at the top right-hand corner of the page. 

**If you are an NPWH member, were once a member, or have taken CE activities with NPWH in the past, you have a username and password in our new system. Please DO NOT create a new account. Creation of multiple accounts could result in loss of CE credits as well as other NPWH services. If you do not remember your username or password, please either click on the "forgot username" or "forgot password" links at the bottom of the sign in screen or call the NPWH office at (202) 543-9693 ext. 1.**


Pricing

Non-Member/Inactive Member Student
$15.00 $10.00 $10.00
Clinical Management of Dilemmas in Contraception (18-04-06)